Xtx Topco LTD Jounce Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.9 - $1.85 $70,371 - $144,651	78,190 New	78,190 $144,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $104,613 - $286,566	37,362 New	37,362 $113,000
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $150,837 - $261,271	-29,928 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.58 - $10.66 $196,926 - $319,032	29,928 New	29,928 $204,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.